Costimulation of T-cell-mediated tumor immunity

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 38, Issue , 1996, Pages

  Hellström, Karl Erik ^a   Chen, Lieping ^a   Hellström, Ingegerd ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

CONFERENCE PAPER; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0029818473     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051036     Document Type: Conference Paper

References (30)

1. Beverley PCL, Sadovnikova E, Zhu X, Hickling J, Chain GB, Collins S, Crawford L, Vousden K, Stauss HJ (1994) Strategies for studying mouse and human immune response to human papillomavirus type 16. Ciba Found Symp 187: 78
2. Bodmer WF, Browning MJ, Krasusa P, Rowan A, Bicknell DC, Bodmer JG (1993) Tumor escape from imuune response by variation in HLA expression and other mechanisms. In: Bystryn J-C, Ferrone S, Livingston P (eds) Specific immunotherapy of cancer with vaccines. New York Academy of Sciences, New York, p 42
3. Boon T (1992) Toward a genetic analysis of tumor rejection antigens. Adv Cancer Res 58: 177
4. Cheever M, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahasi M, Chen W (1995) Immunity to oncogenic proteins. Immunol Rev 145: 33
5. Chen L, Kinney-Thomas E, Hu S-L, Hellström I, Hellström KE (1991) Human papillomavirus type 16 nucleoprotein is a tumor rejection antigen. Proc Natl Acad Sci USA 88: 110
6. Chen L, Mizuno MT, Singhal MC, Hu S-L, Galloway DA, Hellström I, Hellström KE (1992) Induction of cytotoxic T-lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J Immunol 146: 2617
7. Chen L, Ashe S, Brady AS, Hellström I, Hellström KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counter-receptor for the T-lymphocyte molecules CD28 and CTLA-4. Cell 71: 1093
8. Chen L, Linsley PS, Hellström KE (1993) Costimulation of T-cells for tumor immunity. Immunol Today 14: 483
9. Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellström I, Hellström KE (1994) Tumor immunogenicity determines the effect of B7 Costimulation on T cell-mediated tumor immunity. J Exp Med 179: 523
10. Finck BK, Linsley PS, Wofsy D (1994) Successful treatment of murine lupus with CTLA4Ig. Science 265: 1225
11. Garrido F, Cabren T, Concha A, Glew S, Ruiz-Cabello F, Stern PL (1993) Natural history of HLA expression during tumor development. Immunol Today 14: 491
12. Greenberg PD (1991) Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 49: 281
13. Hellström I, Hellström KE (1993) Tumor immunology: an overview. In: Bystryn JC, Ferrone S, Livingston P (eds) Specific immunotherapy of cancer with vaccines. New York Academy of Sciences, New York, p 24
14. Hellström K, Hellström I (1969) Cellular immunity against tumor-specific antigens. Adv Cancer Res 12: 167
15. Hellström KE, Hellström I (1989) Oncogene-associated tumor antigens as targets for immunotherapy. FASEB J 3: 1715
16. Hellström K, Hellström I, Shepard TH (1970) Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium. Int J Cancer 6: 346
17. Hellström KE, Hellström I, Chen L (1994) Can co-stimulated tumor immunity be therapeutically efficacious? Immunol Rev 145: 123
18. Houghton AN, Setaluri V, Bouchard B, Naftzger C, Hara I, Chapman P (1993) Recognition of autoantigens by patients with melanoma. In: Bystryn JC, Ferrone S, Livingston P (eds) Specific immunotherapy of cancer with vaccines. New York Academy of Sciences, New York, p 59
19. Johnston J, Malaco AR, Mizun MT, McGowan P, Hellström I, Hellström KE (1996) B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by MHC class I-restricted CD8+ cytolytic T lymphocytes. J Exp Med 183: 1
20. June CH, Bluestone JA, Nadler LM, Thompson CB (1994) The B7 and CD28 receptor families. Immunol Today 15: 321
21. Li Y, Hellström KE, Ashe Newby S, Chen L (1996) Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors. J Exp Med (in press)
22. Linsley PS, Ledbetter JA (1993) The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11: 191
23. Lloyd KO (1993) Tumor antigens known to be immunogenic in man. In: Bystryn JC, Ferrone S, Livingston P (eds) Specific immunotherapy of cancer with vaccines. New York Academy of Sciences, New York, p 50
24. Masucci MG, Gavioli R, Campos-Lima PO de, Zhang Q-L, Trivedi P, Dolcetti R (1995) Transformation-associated Epstein-Barr virus antigens as targets for immune attack. In: Bystryn J-C, Ferrone S, Livingston P (eds) Specific immunotherapy of cancer with vaccines. New York Academy of Sciences, New York, p 86
25. Melief CJM (1992) Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv Cancer Res 38: 143
26. Melief CJM, Kast WM (1994) Prospects for T cell immunotherapy of tumors by vaccination with immunodominant and subdominant peptides. Ciba Found Symp 187: 97
27. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alterations in signal transduction molecules in T-lymphocytes from tumor-bearing mice. Science 258: 1795
28. Taylor-Papadimitriou J, Stewart L, Burchell J, Beverley P (1993) The polymorphic epithelial mucin as a target for immunotherapy. In: Bystryn JC, Ferrone S, Livingston P (eds) Specific immunotherapy of cancer with vaccines. New York Academy of Sciences, New York, p 69
29. Van Pel A, Bruggen E van der, Coulie PG, Brichard VG, Lethe B, Eynde B van den (1995) Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 145: 229
30. Yang G, Hellström KE, Hellström I, Chen L (1995) Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J Immunol 154: 2794